Precision medicine, testing first. On March 18, at the 2023EBC Eighth Yimao Bio Industry Conference, MGI held the 'DNBSEQ-G99 Signing Ceremony'. Diffei Medical and MGI have officially reached a cooperation to jointly develop application expansion based on G99 to facilitate accurate detection of infectious pathogens and empower high-quality clinical development!

On May 6, the list of Jiangsu Province's 2024 specialized and new small and medium-sized enterprises (the first batch) was announced. After strict selection and review, Difei Medical Technology (Nanjing) Co., Ltd. relied on its focus and breakthroughs in the field of pathogen detection. and innovation, and successfully obtained the 'Specialized, Specialized and New' small and medium-sized enterprise certification!

Dinfectome Inc., announced on Tuesday that its DIFSEQ-200 sequencer gained approval from the Chinese National Medical Products Administration (NMPA) on November 8, 2023